Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Journal of Clinical Medicine|October 19, 2019
The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic PatientsEileen L Yoon, Tae Yeob Kim, Do Seon Song, et al.
Clinical and Molecular Hepatology|July 10, 2013
Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver diseaseYoung Seok Kim, Eun Sun Jung, Wonhee Hur, et al.
Frontiers in Oncology|March 14, 2024
Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative studyJi Won Han, Pil Soo Sung, Jae-Sung Yoo, et al.
International Journal of Cancer|March 14, 2020
Effectiveness of sorafenib dose modifications on treatment outcome of hepatocellular carcinoma: Analysis in real-life settingsKwon Yong Tak, Hee Chul Nam, Jong Young Choi, et al.
Gut and Liver|July 18, 2024
Effect of Biliary Drainage on the Prognosis of Patients with Hepatocellular Carcinoma and Bile Duct InvasionKeungmo Yang, Hyun Yang, Chang Wook Kim, et al.
Journal of Clinical Medicine|September 28, 2021
Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score StudyJaejun Lee, Ji-Won Han, Pil-Soo Sung, et al.
Intervirology|July 5, 2014
Adefovir and lamivudine combination therapy in patients with entecavir-resistant chronic hepatitis B: antiviral responses and evolution of mutationsHyung Joon Yim, Hyun Jung Lee, Sang Jun Suh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2025
Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and BevacizumabJaejun Lee, Keungmo Yang, Ji Won Han, et al.
Hepatology (Baltimore, Md.)|June 25, 2016
Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trialKi Tae Suk, Jung-Hwan Yoon, Moon Young Kim, et al.
NPJ Digital Medicine|May 21, 2026
Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapyJi Won Han, Jaejun Lee, Keungmo Yang, et al.
Pageof 11